Alzamend Neuro is a biotechnology business based in the US. Alzamend Neuro shares (ALZN) are listed on the NASDAQ and all prices are listed in US Dollars. Alzamend Neuro employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $0.22 |
|---|---|
| 52-week range | $0.21 - $1.50 |
| 50-day moving average | $0.42 |
| 200-day moving average | $0.60 |
| Wall St. target price | $3.88 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.14 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.2199 from 2023-09-22
| 1 week (2023-09-15) | -8.37% |
|---|---|
| 1 month (2023-08-24) | -20.04% |
| 3 months (2023-06-23) | -61.08% |
| 6 months (2023-03-24) | -50.02% |
| 1 year (2022-09-23) | -79.73% |
|---|---|
| 2 years (2021-09-24) | -90.84% |
| 3 years (2020-09-20) | N/A |
| 5 years (2018-09-20) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -90.98% |
| Return on equity TTM | -181.47% |
| Profit margin | 0% |
| Book value | $0.03 |
| Market Capitalization | $26.7 million |
TTM: trailing 12 months
We're not expecting Alzamend Neuro to pay a dividend over the next 12 months.
Over the last 12 months, Alzamend Neuro's shares have ranged in value from as little as $0.211 up to $1.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alzamend Neuro's is -0.0835. This would suggest that Alzamend Neuro's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Alzamend Neuro has bucked the trend.
To put Alzamend Neuro's beta into context you can compare it against those of similar companies.
Alzamend Neuro, Inc. , an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. .
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.